Unknown

Dataset Information

Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada.


ABSTRACT: In the past few decades, molecular characterization of thyroid cancer has made significant progress and is able to identify thyroid-cancer-related molecular markers that can then be applied clinically for improved decision making. The aim of this review is to provide a general overview about the molecular markers (mutations and alterations) of thyroid cancers, present several molecular tests, and discuss the clinical applications of identifying these markers supported by the clinical experience of several high-volume thyroid cancer specialists at the McGill university hospitals in Montreal, Canada. Our group experience showed that molecular testing can reclassify more than half of the patients with indeterminate thyroid nodules (Bethesda III and IV) into benign and spare these patients fro

SUBMITTER: Rajab M 

PROVIDER: S-EPMC9454567 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature